Recruiting
Phase 2

Study of Trilaciclib and Lurbinectidin

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT05578326

Conditions

Lung Cancer

Small-cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Trilaciclib

Lurbinectedin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information